asa glp-1 agonists and anesthesia risk: Assessment of gastric content using ultrasound Outpatient Sedation Basics for Patients

[DOI] [PMC free article] [PubMed] [Google Scholar] 83.Radwan RM, Lee YA, Kotecha P, Wright DR, Hernandez I, Ramon R, et al

The question of long-term use To make the matter more complex, initial studies seem to suggest people who lose weight with GLP-1s will need to continue taking the drugs in order to keep the weight off

He is an Assistant Professor, North Ontario School of Medicine, Lakehead University, and Chief of Dentistry, Thunder Bay Regional Health Sciences Center

The primary concern is additive nausea, as both medications list nausea as a common side effect

In a statewide retrospective cohort research involving drug-naive patients with T2D, Currie et al

And with GLP-1 medications, a meaningful portion of what disappears could be lean muscle tissue rather than fat